RNA silencing in Caenorhabditis elegans is transmitted between cells by the transport of double-stranded RNA (dsRNA). The efficiency of such transmission, however, depends on both the cell type and the environment. Here, we identify systemic RNAi defective-3 (SID-3) as a conserved tyrosine kinase required for the efficient import of dsRNA. Without SID-3, cells perform RNA silencing well but import dsRNA poorly. Upon overexpression of SID-3, cells import dsRNA more efficiently than do wild-type cells and such efficient import of dsRNA requires an intact SID-3 kinase domain. The mammalian homolog of SID-3, activated cdc-42-associated kinase (ACK), acts in many signaling pathways that respond to environmental changes and is known to directly associate with endocytic vesicles, which have been implicated in dsRNA transport. Therefore, our results suggest that the SID-3/ACK tyrosine kinase acts as a regulator of RNA import into animal cells.
I ntercellular signaling can occur through the transport of RNA between cells (reviewed in ref. 1) . In some animals such transport occurs in response to the expression or ingestion of double-stranded RNA (dsRNA) and in plants the transport of endogenous RNAs between cells can mediate epigenetic effects during development. The import of dsRNA and mobile silencing RNA into Caenorhabditis elegans cells occurs via a conserved dsRNA transporter called systemic RNAi defective-1 (SID-1) (2) and mammalian homologs of SID-1 have been reported to import dsRNA into cells (3, 4) . Despite this conservation of import mechanisms and the detection of the transfer of RNAs between cultured mammalian cells (5) , the intercellular transport of RNA has not been robustly detected in mammals. In C. elegans, however, transport of silencing RNAs is easily observed from neurons, muscles, and the gut to other tissues (6) . However, the efficiency of such transport varies between cell types (6) and is influenced by environmental conditions, such as starvation (2) or the presence of excess environmental dsRNA (7) . Furthermore, this variation may underlie the inability to detect RNA transport between C. elegans cells in some studies (8, 9) . Similar differences have also been reported in Drosophila: silencing triggered by injected dsRNA spreads throughout the fly (10) but silencing triggered by the expression of dsRNA in specific tissues does not (11) . A possible explanation for this variation in the detection of RNA transport between cells is that there are mechanisms that interfere with such transport. Therefore, the identification of signaling pathways that control the efficiency of RNA transport could both enable the discovery of mechanisms that modulate RNA transport in response to the environment and enhance the reliable detection of RNA transport between cells in animals.
Results

sid-3
Encodes the C. elegans Ortholog of Mammalian Activated cdc-42-Associated Kinase. We previously used a genetic screen in C. elegans to identify genes that control the transport of RNA between cells (2) . These systemic RNAi defective (sid) mutants comprise three large complementation groups: sid-1, sid-2, and sid-3. The sid-1 gene encodes a conserved membrane protein with multiple transmembrane domains that imports silencing RNAs into cells (2, 6, 12, 13) ; sid-2 encodes a single-pass transmembrane domain protein that is required for the import of ingested dsRNA across the gut luminal membrane (14) . In this study, we present the analysis of sid-3.
For the sid screen (2), we created a transgenic strain that allows for rapid discrimination between mutants simply defective for RNAi and mutants defective in the transport of RNA silencing signals. Animals of this strain express GFP in two tissues, the pharynx and the body wall muscle (bwm) cells, and also express gfp-dsRNA in the pharynx. In wild-type animals the pharyngeally expressed gfp-dsRNA silences pharyngeal GFP expression and, via the transport of silencing signals, also silences some anterior bwm cell GFP expression. When these animals are grown on bacteria that express gfp-dsRNA, then all anterior and posterior bwm cells are also silenced (Fig. 1A , Upper), making the strain suitable for large-scale phenotypic screening. In RNAidefective mutants, silencing is not observed in any tissue, but in mutants defective in the uptake of dsRNA from the environment (e.g., sid-2), strong silencing of GFP expression is observed in pharyngeal and some anterior bwm cells but not in posterior bwm cells. In systemic RNAi mutants (e.g., sid-1) the strong silencing of pharyngeal GFP remains intact, but silencing in bwm cells, which is dependent on mobile silencing signals, is not observed. All isolated sid-3 mutants (14 alleles) appeared similar to sid-1 mutants in that silencing of the bwm cell GFP expression was greatly reduced but, unlike sid-1-null mutants, was not eliminated (Fig. 1A, Lower) . In addition, GFP expression in the pharynx was silenced to a greater extent in sid-3(−) animals than in wild-type animals (Fig. 1A) . Taken together, our results suggest that sid-3 mutants are defective in the transport of silencing RNAs.
We used two-factor mapping to narrow the location of the sid-3 mutation to a small region of the C. elegans genome. To determine whether these recombinants were Sid, we used the highly penetrant resistance of sid-3 mutants to feeding RNAi of GFP (Fig. 1A) or of the germ-line and embryonic gene pal-1 (15) . This mapping placed sid-3 to the right of the visible marker unc-3 on the X chromosome (Fig. S1A ) in a region with significantly reduced recombination (16) . To enable the isolation of recombinants in this region, we used a dpy-28(−)/dpy-28(+) background, which increases the crossover frequency in this region (16) . Using this approach, we isolated 286 recombinants between the N2 and CB4856 polymorphic strains that had recombined to the right of unc-3 (Fig. S1A) . Analysis of these recombinants narrowed the region containing sid-3 to the terminal 588 kb of the X chromosome (Fig. S1A) . To identify DNA sequence changes within the sid-3 region associated with the sid-3(qt40) allele, we sequenced the genomic DNA from sid-3(qt40) animals using whole-genome sequencing (17) . We identified a point mutation that results in a premature stop codon in the gene B0302.1 (Fig.  S1 B and C) , the exon-intron structure of which (Fig. 1B) is well supported by RNA-Seq data for each developmental stage (Fig.  S2) . We next sequenced DNA corresponding to the exons and exon-intron junctions of B0302.1 from 12 additional sid-3 mutant alleles. In all, 9 of the 13 alleles had point mutations or small deletions that result in premature stop codons in the corresponding protein; one had a splicing acceptor mutation; and two others had missense mutations that drastically altered conserved residues (Gly to Asp and Arg to Gln). (Fig. 1B and Figs. S3, S4 , and S5). These observations suggest that severe disruption of the SID-3 protein is required to cause a readily detectable defect in mobile RNA silencing in our genetic screen. Confirming the gene identity of sid-3, we found that overexpression of genomic DNA containing B0302.1 along with its promoter and 3′ UTR regions robustly rescued the silencing defect in sid-3(−) animals (Fig. 1C, 
C.e ARK-1 Right). Interestingly, compared with wild-type animals, sid-3(−) animals that overexpress sid-3(+) showed silencing of GFP expression in a greater number of bwm cells (expressivity) and showed robust silencing in a larger fraction of the animals (penetrance) (Fig. 1D) . Thus, B0302.1 encodes SID-3 and the extent of silencing because of mobile silencing RNA depends on the level of SID-3 expression.
The sid-3 gene encodes a conserved protein with a tyrosine kinase domain, a Src homology 3 (SH3) domain, and a Cdc42/ Rac interactive binding (CRIB) domain ( Fig. 1 B and E, and Fig.  S4 ). This domain composition is present in the activated Cdc-42-associated kinase (Ack) family of cytoplasmic tyrosine kinases ( Fig. 1E and Fig. S4) (reviewed in ref. 18 ). C. elegans contains two members of this broadly conserved family of tyrosine kinases: SID-3 and Ack related kinase-1 (ARK-1). Phylogenetic analysis suggests that the kinase domain of SID-3, rather than that of ARK-1, is more closely related to human ACK (Fig. 1F) . Although both ARK-1 and SID-3 are more similar to ACK than the other human Ack-family protein TNK1 (Fig. 1G) , ark-1(−) animals do not have a defect in silencing because of mobile RNA (Fig. 1H) . To test whether ACK can rescue the silencing defects in sid-3(−) animals, we transformed sid-3(−) animals with a mouse ACK cDNA under the control of either the sid-3 promoter or a bwm promoter (see SI Materials and Methods for details). In both cases, we failed to obtain viable transgenic lines but observed larval and embryonic lethality in the progeny of injected animals. Thus, although it remains unclear whether ACK can functionally replace SID-3 in systemic RNAi, the sequence similarity and analysis of ark-1(−) animals suggest that SID-3 is the only C. elegans ortholog of the mammalian ACK protein with a defect in the transport of mobile RNA.
SID-3 Is Required for Efficient Feeding RNAi in all Tested Tissues and Is
Localized in the Cytoplasm of Many Tissues. To test whether sid-3(−) animals have defects in RNA silencing beyond the inability to silence GFP expression in bwm cells in response to mobile RNA, we examined their response to feeding RNAi of genes expressed in multiple tissues. Using two outcrossed sid-3 null mutants [sid-3 (W310Stop) and the sid-3(tm342) deletion that leads to a premature stop codon], we tested the requirement for sid-3 to silence skin-(dpy-7), muscle-(unc-22 and unc-45), germ line-(par-1 and pos-1), and intestine-expressed (act-5) genes (Fig. 2 A-C) . In all cases, sid-3 null mutants were measurably defective in silencing the target gene, although the severity of the defect varied among tissues and was often less penetrant than sid-1-null mutants (e.g., germ-line and intestinal genes). In particular, sid-3(−) animals were only mildly defective in silencing the intestine-expressed gene act-5. This observation suggested that, unlike SID-1 or SID-2, the SID-3 protein may not be required for the import of ingested dsRNA into intestinal cells but rather is required for the subsequent export of dsRNA from intestinal cells to internal tissues. Because the sur-5::gfp transgene expresses nuclear-localized GFP in all somatic cells, which is easily observed in the large intestinal nuclei, we measured the extent of GFP silencing in intestinal nuclei of individual sid-3(−);sur-5::gfp animals in response to gfp feeding RNAi. We found that sid-3(−) animals clearly showed a measurable defect in silencing GFP expression in intestinal cells, although they were more silenced than the completely defective sid-1(−) animals (Fig. 2 D-G) . In summary, these results suggest that because SID-3 is required to fully silence genes expressed in many tissues, including intestinal cells in response to ingested dsRNA, sid-3 is likely to function broadly to control silencing in most tissues.
To determine the tissues that express the sid-3 gene, we constructed reporters designed to express either GFP or DsRed under the control of the sid-3 promoter and 3′ UTR regions that were used to rescue sid-3(−) in Fig. 1 . These transcriptional reporters were expressed in multiple distinct cell types, including the gut, pharynx, bwm, skin, and excretory canal cells (Fig. 3) . To examine the subcellular localization of the SID-3 protein, we generated translational reporter constructs designed to express a SID-3::DsRed fusion protein under the control of the same sid-3 promoter and 3′ UTR regions used above. The SID-3::DsRed fusion protein rescued the silencing defects in sid-3(−) animals (100% of animals expressing SID-3::DsRed showed silencing upon dpy-7 feeding RNAi) and, similar to the mammalian Ack proteins (19) , was localized within the cytoplasm of cells in a diffuse as well as punctate pattern in all examined tissues (Fig. 3) . To ensure that the punctate localization of SID-3::DsRed was not a result of nonspecific aggregation induced by fusion to the DsRed protein, we similarly generated a SID-3::GFP fusion protein. This fusion protein was also broadly expressed and localized to the cytoplasm of cells in a diffuse as well as punctate pattern (Fig. S6) .
These results suggest that the SID-3 protein likely functions in the cytoplasm of most tissues to enable efficient RNAi in response to ingested dsRNA.
SID-3 Is Not Defective in Cell-Autonomous RNAi but Is Defective in the
Transport of RNA Between Cells. This broad distribution of SID-3 could reflect that SID-3 is necessary for the efficient execution of RNAi (cell-autonomous RNAi) in all tissues or that SID-3 is necessary for the efficient transport of dsRNA to all tissues. The lack of a silencing defect in pharyngeal cells that express dsRNA (Fig. 1B) suggests that the ability to execute RNAi is not compromised in sid-3(−) animals. However, because the level of dsRNA expression in the pharynx is unknown, a high level of dsRNA expression in the pharynx could mask a mild defect in the execution of RNAi in sid-3(−) animals.
To clearly distinguish defects in the execution of RNAi from defects solely in the transport of dsRNA, we measured the response of sid-3(−) animals to known amounts of dsRNA injected into cells. Specifically, we injected different concentrations of dsRNA targeting an embryonic gene (pal-1) directly into both gonad arms of animals and measured the fraction of progeny that showed embryonic lethality (Fig. 4A) . The germ line within the gonad is syncytial and so does not require dsRNA transport for silencing. Wild-type animals injected with increasing concentrations of pal-1-dsRNA laid an increasing proportion of dead progeny. The lethality was specifically caused by RNAi because no lethality was observed at any of the concentrations tested in rde-1(−) animals, which are resistant to RNAi. In this assay, sid-3 mutants laid a greater proportion of dead progeny than did wildtype animals at all dsRNA doses. This finding suggests that cellautonomous RNAi may be enhanced in sid-3(−) animals. To test this possibility rigorously we used a single needle containing a limiting but identical concentration (10 ng/μL) of pal-1-dsRNA to inject both gonad arms of 10 wild-type worms and 10 sid-3(−) worms. We then measured the proportion of dead progeny laid by each doubly injected animal (Fig. 4B) . Although sid-3(−) animals appear marginally more sensitive to silencing than wild-type animals, these results were statistically indistinguishable (P > 0.05 Mann-Whitney U test). Nevertheless, these results clearly demonstrate that sid-3 mutants are not defective in the execution of RNAi. Furthermore, the minor enhanced RNAi observed in response to injection of dsRNA into the germ line and the enhanced silencing of pharyngeal GFP because of gfp-dsRNA expression within the pharynx (Fig. 1A) suggest that sid-3 mutants may even be enhanced for the execution of RNAi. Therefore, our results are consistent with the idea that the partial silencing defect in response to mobile RNA observed in sid-3(−) animals solely reflects a defect in RNA transport between cells.
SID-3 Is Required for the Import of Silencing RNA into Cells but Not for Their Export from Cells. SID-3 may control the export and the import of dsRNA as well as of mobile silencing RNA, which are also forms of dsRNA (20) . To evaluate the roles of SID-3 in RNA transport between cells, we rescued sid-3(−) animals in gfpdsRNA-expressing donor tissue or in GFP-expressing recipient tissue and measured silencing of GFP in the recipient tissue (Fig. 4  C and D) . Specifically, we used sid-3(−) animals that express GFP and gfp-dsRNA in the pharynx (donor) and that express GFP in the bwm cells (recipient). Expression of sid-3(+) under the control of a pharynx-specific promoter failed to rescue GFP silencing in bwm cells, suggesting that SID-3 does not have a detectable effect on the efficiency of export of mobile silencing RNA. In contrast, expression of sid-3(+) under the control of a bwm-specific promoter robustly rescued GFP silencing in bwm cells, suggesting that SID-3 plays a role in controlling the efficiency of mobile silencing RNA import into recipient cells. Thus, these results support the idea that SID-3 is specifically required to ensure the efficient import of mobile silencing RNA and dsRNA into C. elegans cells.
Tyrosine Kinase Domain of SID-3 Is Required for the Efficient Import of dsRNA into Cells. SID-3 contains several conserved protein interaction domains (Fig. 1B) and thus may play a structural rather UTR. Left Insets are differential interference contrast images and Right Insets are merged red and green channel images. Fluorescence from SID-3::DsRed fusion was detected diffusely throughout the cytoplasm and in cytoplasmic foci. Similar diffuse and focal expression was also observed using a SID-3:: GFP fusion protein (Fig. S6) . Note that extrachromasomal arrays, which express the fluorescent proteins above, are lost mitotically, resulting in mosaic expression. For the more stable extrachromosomal arrays, the mosaic expression patterns largely match the known cell lineage. (Scale bars, 20 μm.)
than a catalytic role to promote the import of dsRNA into cells. Curiously, 10 of 13 recovered mutants contain nonsense, smalldeletion, or splice-site mutations that via nonsense-mediated decay would result in substantially reduced mRNA levels and produce at most truncated proteins. In addition, although we isolated two missense mutants, both in the tyrosine kinase domain, modeling the mutations on the known crystal structure of the ACK tyrosine kinase domain (21) shows that these mutations are distant from the catalytic residues important for kinase activity and ATP binding (Fig. S5) . To directly evaluate the requirement for an active kinase domain, we tested whether a kinase-dead SID-3 protein can rescue the silencing defect in sid-3 mutants. Specifically, we transformed sid-3 mutant animals with constructs that express either wild-type SID-3 or a SID-3(K139A) mutant protein. This lysine residue corresponds to ACK1(K158), which is required for ATP binding (21, 22) . We then evaluated the silencing of GFP expression in bwm cells in response to gfp feeding RNAi and gfp-dsRNA expression in the pharynx. Unlike constructs that express wild-type SID-3, constructs that express SID-3(K139A) failed to rescue bwm silencing (Fig. 5) . Thus, the kinase activity of SID-3 is essential to enable efficient import of dsRNA into C. elegans cells.
Discussion
We have shown that: (i) SID-3 functions in the importing cell to enable silencing by mobile RNA; (ii) SID-3 function requires an intact kinase domain; (iii) cells that lack SID-3 are not defective, but are marginally enhanced for cell-autonomous RNAi; and (iv) overexpression of SID-3 enhances silencing because of mobile RNA. Taken together, these observations suggest that the conserved tyrosine kinase SID-3 promotes dsRNA import into cells. Three considerations lead us to speculate that SID-3/ACK functions to enhance the endocytic import of dsRNA into animal cells. First, the ACK tyrosine kinase was initially identified as a protein that binds and prolongs the activity of Cdc42 (23), a small GTPase that promotes endocytosis (24) . Notably, the CRIB domain required for this binding is highly conserved (56% identical) between the human ACK protein and SID-3 (Fig. 1E) . Second, a screen using Drosophila cultured cells revealed a conserved role for clathrin-mediated endocytosis in the import of dsRNA into S2 cells (25) . Third, in cultured mammalian cells, activated ACK associates with Cdc42 and invaginated endocytic vesicles (26) . Consistent with a possible role for SID-3-dependent tyrosine phosphorylation in endocytosis, the C. elegans dynamin, DYN-1, was recently found to be phosphorylated at a tyrosine (27) . Thus, signaling through the SID-3/ACK tyrosine kinase may promote the endocytic uptake of dsRNA for the eventual import into the cytoplasm through the conserved dsRNA transporter SID-1 in C. elegans and in mammals. Signaling through ACK is activated by multiple extracellular stimuli that include growth factors and cell attachment (28) . Therefore, the receptivity of animal cells for dsRNA uptake may be sensitive to developmental or environmental animals that express GFP in the pharynx and in bwm cells but express gfp-dsRNA only in the pharynx were transformed with constructs that express sid-3(+) under the control of its own (sid-3), bwm-specific (bwm), or pharynx-specific (phar) promoter and the percentage of transgenic animals that show gfp silencing in bwm cells was determined. Error bars indicate 95% confidence intervals. n = 100 L4 animals; *P < 0.05.
C sid-3(-); qtEx [Pmyo-3::sid-3(KD-)]
silenced bwm cells signals that activate the tyrosine kinase SID-3/ACK to promote the import of mobile silencing RNA.
B sid-3(-); qtEx [Pmyo-3::sid-3(+)] A sid-3(-)
Materials and Methods
Worm strains and transgenic animals were generated and maintained using standard methods (6) . The position of sid-3 was narrowed using SNP mapping and the corresponding mutation was identified using whole-genome sequencing (17) . Rescues of sid-3 mutants were performed using PCR products amplified from genomic DNA and fused with different promoter sequences. Resistance to RNAi was evaluated using feeding RNAi or injection of dsRNA. Detailed procedures and a list of the PCR primers used are provided in SI Materials and Methods.
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Jose et al. 10 .1073/pnas.1201153109 SI Materials and Methods Strains Used. N2 Bristol wild-type (used in all experiments except mapping), CB4856 Hawaiian wild-type, HC57 qtIs3(Pmyo2:: gfphpRNA);mIs11(Pmyo2::GFP);ccIs4251(Pmyo3::GFP) (1), HC114 qtIs3;mIs11;ccIs4251;sid-1(qt9) (1), HC115 ccIs4251;unc-6(e78) dpy-6(e14) sid-3(qt14), HC111 qtIs3;mIs11;ccIs4251;sid-3(qt11), HC118 qtIs3;mIs11;ccIs4251;sid-3(qt16), HC120 qtIs3;mIs11;ccIs4251;sid-3(qt18), HC152 qtIs3;mIs11;ccIs4251;sid-3(qt27), HC153 qtIs3; mIs11;ccIs4251;sid-3(qt28), HC154 qtIs3;mIs11;ccIs4251;sid-3(qt29), HC156 qtIs3;mIs11;ccIs4251;sid-3(qt31), HC157 qtIs3;mIs11; ccIs4251;sid-3(qt32), HC161 qtIs3;mIs11;ccIs4251;sid-3(qt36), HC162 qtIs3;mIs11;ccIs4251;sid-3(qt37), HC163 qtIs3;mIs11; ccIs4251;sid-3(qt38), HC164 qtIs3;mIs11;ccIs4251;sid-3(qt39), HC165 qtIs3;mis11;ccIs4251;sid-3(qt40), HC195 nrIs20[sur-5:: gfp], HC196 sid-1(qt9), HC566 nrIs20; sid-1(qt9), HC769 sid-3(qt31) [outcrossed twice to N2], HC770 sid-3(tm342) [outcrossed twice to N2], HC771 nrIs20;sid-3(tm342), MT11836 ark-1(n3701), PS1461 ark-1(sy247), WM27 rde-1(ne219), and TY148 dpy-28(y1).
SNP Mapping. Two-factor mapping indicated that sid-3 is located in a region of recombination suppression to the right of unc-3 on the X chromosome (2). Specifically, using the sid-3(qt40) allele, we found that 9/9 Dpy-6-non-Unc-3 were systemic RNAi defective (Sid) (as evidenced by resistance to pal-1 feeding RNAi) and 28/28 Unc-3-non-Dpy-6 animals were non-Sid (as evidenced by sensitivity to pal-1 feeding RNAi). A dpy-28(−)/dpy-28(+) background was used to increase recombination in this region (2). HC115 was crossed into a strain that was Hawaiian on the X chromosome but that had dpy-28(y1) in the background and recombinants that separate unc-6 and dpy-6 from sid-3 were isolated. These recombinants were tested for the following SNPs between the Bristol and Hawaiian strains: pkP6167, pkP6168, pkP6169, pkP6170, pkP6171, and pkP6172, haw111990, and CE6-243. The SNPs were identified using primers as listed in wormbase (www.wormbase.org) and either restriction enzyme digests or Sanger sequencing. Using this approach, 286 recombinants were analyzed to position sid-3 to the terminal ∼588-kb region after haw111990 on the X chromosome.
Outcross and Genotyping. The sid-3(qt31) mutation was isolated from the GFP and gfp-pfg hpRNA transgenes by backcrossing HC156 with N2 twice. Successful backcrosses were identified by the lack of GFP expression and restriction fragment length polymorphisms. The region containing the point mutation (qt31) was amplified through PCR with primers P55 and P56, and then cut with the enzyme NcoI, which cuts wild type but not the mutant. sid-3(tm342) was made from heterozygotes of a deletion in B0302.1, tm342 (National Bioresource Project for the nematode and Shohei Mitani, Department of Physiology, Tokyo Women's Medical University School of Medicine, Tokyo, Japan), by backcrossing with N2 twice. The deletion was followed using a set of primers (P51, P52, P54) that yielded different length PCR fragments for wild-type and the deletion.
Preparation of Sample for Whole-Genome Sequencing and Verification
by T/A Cloning. HC165 genomic DNA was purified to eliminate RNA using a protocol adapted from Qiagen Puregene Core Kit and the Hobert Laboratory (3), and the DNA concentration was measured using a NanoDrop spectrophotometer. Next, 1.5 μg of the DNA (406.4 ng/μL) was fragmented for 20 min with Fragmentase (New England Biolabs). End repair, addition of a 3′ A, and ligation of Illumina adapters were done as per the protocol from Illumina (3). The resultant library was then run on a 2% (wt/ vol) agarose gel and bands from 100 to 250 bp were excised and purified using Gel Extraction Kit (Qiagen) and MinElute PCR Purification Kit (Qiagen). The library was amplified using Illumina primers complementary to the adapter sequences. The final concentration of the library was 19.5 ng/μL. Using the StrataClone PCR Cloning Kit (Stratagene), DNA from the library was inserted into plasmids with LacZ and ampicillin resistance through TA TOPO cloning. StrataClone competent cells were transformed with the plasmid and grown on Luria broth plates with 100 μg/mL of carbenicillin for blue/white color screening. White or light blue colonies were picked and the inserts were Sanger-sequenced. Thirteen of the 15 distinct insert sequences obtained mapped to the Caenorhabditis elegans genome and two mapped to the Escherichia coli genome (likely from contaminating food). Because a majority of the sequences were from HC165, we proceeded with this library for whole-genome sequencing.
Bioinformatic Analysis After Whole-Genome Sequencing. We obtained 22,005,912 reads that were each 42 bases long from sequencing (Illumina GAII system). We used Galaxy (4) (5) (6) to analyze and align the reads to the C. elegans genome (ce6). These Illumina reads were entered into Galaxy and 21.7 million reads of good quality were culled (quality score ≥10 and maximum number of bases allowed outside of quality for each read was 3). As 3′ ends were more variable in quality, we trimmed three bases off the 3′ ends to increase alignment fidelity. Upon alignment, 81% of the reads (i.e., 17,583,185 reads with a read length of 39 bases) mapped to the C. elegans genome for a 6.85× coverage of the genome. Of the mapped reads, we filtered for reads on the X chromosome to the right of haw111990, leaving 472,865 reads. From these reads, we filtered for candidate mutations (covered by at least one read and with more than half the reads different from the reference sequence) to obtain 32 candidates.
Testing the Candidate Mutations. Regions containing each of the candidate mutations were amplified by PCR using 25 sets of primers (P1-P50). The PCR products were purified using Qiagen PCR Column Purification and Sanger-sequenced. Nine of these products were successfully sequenced and three of the nine (one in an exon, two in introns) were confirmed as true mutations. The remaining six were false-positives from Illumina sequencing that did not reconfirm by Sanger sequencing. Unlike the falsepositives, the three mutations confirmed were strong candidates as all of the Illumina reads that covered the corresponding base had the mutation.
Sequencing the Other Alleles of sid-3. To find the mutations in the 12 remaining alleles of sid-3 other than qt40 (used for Illumina sequencing) and tm342 (known deletion), we designed primers (P51-P70) to sequence all of the known exons of B0302.1 according to Wormbase and confirmed by the modENCODE project (Fig. S2) . Parts of the gene that contain exons were amplified by PCR (Fig. S3 ) and the PCR products were then purified using PCR Column Purification kit (Qiagen) and Sanger-sequenced.
DNA Constructs and Transgenesis. Coinjection markers. The plasmids pRF4 (7), pHC183 (1), and pHC448 (8) were used to obtain transgenic animals that roll, express DsRed2 in the body wall muscles (bwm), or express DsRed2 in the pharynx, respectively. PCR fusion products. Except as noted, promoter, gene, and 3′ UTR sequences were amplified from genomic DNA or plasmid sources with PfuUltraII Fusion Polymerase (Agilent) by using primers that result in a ∼50 bp overlap between the two PCR fragments. The fusion products, along with specified coding and noncoding sequences, were generated with expand long template (ELT) polymerase (Roche) by using nested primers along with the amplified promoter and the coding sequences as template. In some cases, the two or three PCR fragments were fused in vivo. The specific templates and primers used to generate the various PCR fusion products are detailed below. To rescue sid-3. The entire sid-3 gene plus 6 kb of its upstream promoter region and 450 bp of its 3′ UTR was amplified using the ELT PCR system (Roche) with primers P71 and P72. Two overlapping 10-kb fragments that span the 13-kb region containing sid-3 was used as template to amplify sid-3 for Fig. 1 . In all other cases, N2 genomic DNA was used as template to amplify sid-3 sequences. The amplified DNA (10 ng/μL) and pHC183 (38 ng/μL) was injected into HC156 and HC769 to generate a transgenic line.
To express sid-3 in the pharynx (Pmyo2::sid-3 gDNA and 3′ UTR). The myo-2 promoter was amplified from pHC168 with primers P73 and P74. Sid-3 with its 3′ UTR was amplified from N2 gDNA using ELT polymerase with primers P75 and P76. The fusion product was generated with primers P73 and P77. A 1:4 mix of Pmyo2::sid3 gDNA and 3′ UTR (10.5 ng/μL) and the coinjection marker pHC448 (38 ng/μL) was injected into HC769 animals to generate transgenic lines.
To express sid-3 in the body wall muscles (Pmyo3::sid3 gDNA and 3′ UTR).
The myo-3 promoter was amplified from pHC183 with primers P77 and P78. sid-3 with its 3′ UTR was amplified from gDNA using ELT polymerase with primers P79 and P76. The fusion product was generated with primers P77 and P82. A 1:4 mix of Pmyo-3:sid-3 gDNA and 3′ UTR (10.8 ng/μL) and pHC183 (45 ng/μL) was injected into HC769 animals to generate transgenic lines.
To produce a transcriptional reporter of sid-3 expression with GFP (Psid-3::
gfp::sid-3 3′ UTR). The 3′ UTR of sid-3 was amplified from gDNA with primers P81 and P76. The gfp coding sequence was amplified from pJM46a using primers P82 and P83. The fusion product gfp::sid-3 3′ UTR was generated with primers P84 and P85. The sid-3 promoter was amplified from gDNA using ELT polymerase and with primers P86 and P87. The final fusion product Psid-3::gfp::sid-3 3′ UTR was generated with primers P71 and P77. A 1:4 mix of Psid-3::gfp::sid-3 3′ UTR (10.35 ng/μL) and the coinjection marker pRF4 (44 ng/μL) was injected into HC769 animals to generate transgenic lines.
To produce a transcriptional reporter of sid-3 localization with DsRed2 (Psid-3::DsRed2::sid-3 3′ UTR). The 3′ UTR of sid-3 was amplified from gDNA with primers P88 and P76. The DsRed2 coding sequence was amplified from pHC183 using primers P82 and P89. The fusion product DsRed2::sid-3 3′ UTR was generated with primers P90 and P84. The sid-3 promoter was amplified from gDNA using ELT polymerase and with primers P86 and P91. The final fusion product Psid-3::DsRed2::sid-3 3′ UTR was generated with primers P71 and P77. A 1:4 mix of Psid-3::DsRed2:: sid-3 3′ UTR (10 ng/μL) and the coinjection marker pRF4 (44 ng/μL) was injected into HC769 animals to generate transgenic lines.
To express a translational fusion of sid-3 with DsRed2 (Psid-3::sid-3 gDNA::
DsRed2::sid-3 3′ UTR). The sid-3 3′ UTR was amplified from gDNA with primers P88 and P76. The DsRed2 coding sequence was amplified from pHC183 with primers P82 and P89. The fusion product gfp::sid-3 3′ UTR was generated with primers P90 and P84. The sid-3 promoter along with sid-3 was amplified from gDNA with primers P86 and P92. The final fusion product, Psid-3::sid-3::DsRed2::sid-3 3′ UTR, was generated with primers P71 and P77. A 1:1 mix of Psid-3::sid-3::DsRed2::sid-3 3′ UTR (16.65 ng/μL) and the coinjection marker Psid-3::gfp::sid-3 3′ UTR (10.35 ng/μL) was injected into HC769 animals to generate transgenic lines.
To express sid-3(KD−) in bwm cells. The myo-3 promoter was amplified from pHC183 with primers P93 and P94 using Phusion polymerase mix. The sid-3 coding sequence up to the kinase domain was amplified from wild-type gDNA with primers P95 and P96 using Phusion polymerase mix. The remainder of the sid-3 gene including the 3′ UTR was amplified using P97 and P98 from wild-type gDNA with ELT polymerase. An equimolar mix of Pmyo-3 (3.8 ng/μL), sid-3 up to kinase domain (4 ng/ μL), sid-3 from kinase domain to 3′ UTR (14.6 ng/μL) was injected into HC156 animals along with the coinjection marker pHC183 (20 ng/μL) to generate transgenic lines. This construct is expected to express SID-3(K139A), a kinase-dead version of SID-3.
To express sid-3(+) in bwm cells as control for sid-3(KD−) expression. The myo-3 promoter was amplified from pHC183 with primers P93 and P94 using Phusion polymerase mix (New England Biolabs). The sid-3 coding sequence up to the kinase domain was amplified from wild-type gDNA with primers P95 and P99 using Phusion polymerase mix. The remainder of the sid-3 gene including the 3′ UTR was amplified using P100 and P98 from wildtype gDNA with ELT polymerase. An equimolar mix of Pmyo-3 (3.8 ng/μL), sid-3 up to kinase domain (4 ng/μL), sid-3 from kinase domain to 3′ UTR (14.6 ng/μL) was injected into HC156 animals along with the coinjection marker pHC183 (20 ng/μL) to generate transgenic lines.
To express mouse activated cdc-42-associated kinase in bwm cells. The myo-3 promoter was amplified from pHC183 with primers P101 and P102 using Phusion polymerase mix. The activated cdc-42-associated kinase (ack) cDNA was amplified from pYX-Asc +TNK2 (Source Bioscience) with primers P103 and P104 using Phusion polymerase mix. The unc-54 3′ UTR was amplified using P105 and P106 using Phusion polymerase from pHC183. An equimolar mix of Pmyo-3 (4 ng/μL), ack cDNA (4 ng/μL), and unc-54 3′ UTR (14.6 ng/μL) was injected into HC156 animals along with the coinjection marker pHC183 (20 ng/μL) to generate transgenic lines.
To express ACK under the control of the sid-3 promoter as a translational fusion in C. elegans (Psid-3::ack::gfp::sid-3 3′ UTR). The sid-3 3′ UTR was amplified from gDNA with primers P107 and P108. The gfp coding sequence was amplified from pPD95.75 with primers P109 and P110. The fusion product gfp::sid-3 3′UTR was generated with primers P111 and P112. This fusion product, the sid-3 promoter, amplified from gDNA, and ACK-1 cDNA were injected along with the coinjection marker pHC183 into HC769 animals to generate transgenic lines where the PCR products would be fused in vivo.
To express a translational fusion of sid-3 with gfp (Psid-3::sid-3 gDNA::
gfp::sid-3 3′ UTR):. The gfp coding sequence was amplified from pPD95.75 with primers P113 and P114 using Phusion polymerase mix (New England Biolabs). The sid-3 3′ UTR was amplified from gDNA with primers P115 and P116 using Phusion polymerase mix. The sid-3 promoter along with sid-3 was amplified from gDNA with primers P117 and P118 using ELT polymerase. An equimolar mix of Psid-3::gsid-3 (20 ng/μL), GFP (1.5 ng/μL), and sid-3 3′ UTR (1 ng/μL) along with the coinjection marker pRF4 (20 ng/μL) was injected into HC769 animals to generate transgenic lines where the PCR products would be fused in vivo.
In most cases, transgenic animals were healthy and appeared morphologically normal, with the following exceptions. The attempt to express mouse ACK in C. elegans resulted in embryonic and larval lethality in the progeny of injected animals. Overexpression of wild-type sid-3(+) in body-wall muscles or under the control of its own promoter using in vivo fusion as above resulted in many transgenic animals with vulval, egg-laying, and movement defects.
Feeding RNAi of Endogenous Genes. E. coli expressing either dsRNA targeting a particular C. elegans gene (Geneservice) or control dsRNA (L4440) was fed to L4-staged animals on agar plates containing 1 mM isopropyl β-D-1-thiogalactopyranoside. Progeny of these animals were examined for the corresponding defects. To measure brood size for pal-1 and pos-1 RNAi, three plates containing three L4 animals each were fed either RNAi food or control food and the animals moved to a new plate of the corresponding food after 2 d. All hatched progeny on the first plate were counted 2 d later (on day 4) and all hatched progeny on the second plate were counted 2 d after that (on day 6). The average brood size of the three plates of control food was used to normalize the brood size on each of the three RNAi food plates. For act-5, progeny of stage L4 and older were similarly counted and normalized. For dpy-7, the percentage of young adult progeny that were dumpy was calculated. Only those that were strongly dumpy were counted as dumpy. None of the control RNAi food plates showed any dumpy progeny. For unc-22, we counted percentages of L4 larvae that twitched and adults that were paralyzed. Worms unable to move upon tapping the plate were scored as paralyzed. For unc-45, the percentage of paralyzed L4 progeny was determined.
gfp-Feeding RNAi. For gfp feeding RNAi, E. coli that expresses gfphpRNA (hairpin RNA) from the plasmid pPD126.25 was put onto nematode growth (NG) plates (3 g NaCl, 17 g agar, 2.5 g peptone, 1 mM CaCl 2 , 5 mg of cholesterol, 1 mM MgSO 4 , 25 mM KPO 4 in 1 L of H 2 O) and three L4 worms were placed on the E. coli (9) . OP50 on NG plates was used as control. After 4 d, 25 or 50 L4 progeny were picked under white light (for unbiased picking) and put on a new plate. These L4 progeny were then scored for GFP silencing using a dissecting fluorescent microscope at a fixed magnification.
Injection RNAi of pal-1. We used T7 RNA polymerase to transcribe in vitro dsRNA that targets the pal-1 gene. A PCR product amplified from genomic DNA with dual T7 primers was used as a template to generate dsRNA. The transcribed RNA was annealed and quantified using a spectrophotometer (NanoDrop). In Fig. 4A , different concentrations of dsRNA were injected into both gonad arms of three young adult animals (24 h after L4) for each genotype and the proportion of dead progeny among progeny laid 12 h after injection was counted. In Fig. 4B , 10 ng/μL of dsRNA was injected into both gonads of 10 wild-type and 10 sid-3(qt31) animals using the same needle and alternating between the two genotypes. The proportion of dead embryos among progeny laid within a 60-h period beginning 12 h after injection was determined for each injected animal.
Phylogeny. The amino acid sequences of the kinase domains of the two Ack family proteins from C. elegans (SID-3 114-363 aa and ARK-1 120-376 aa), D. melanogaster (DACK 130-383 aa and DPR2 140-396 aa), and H. sapiens (ACK 196-148 aa and TNK1 123-377 aa) were used for phylogenetic analysis. The phylogeny tree was manually compiled using MUSCLE, Gblocks, PhyML, and TreeDyn at Phylogeny.fr (10) . Branches with a bootstrap value <95% were collapsed to generate the final tree. The tree was arbitrarily rooted to the single resolved internode.
Statistics. The 95% confidence intervals for dpy-7, unc-22, unc-45 feeding were calculated from Wilson's estimates with continuity correction (11) . The 95% confidence intervals for pal-1, pos-1, act-5 feeding were calculated using the Student t test. Significance of differences in the pal-1 dsRNA injection experiments were assessed using the Mann-Whitney U test.
Live Microscopy. Worms were immobilized using 3 mM levamisole (Sigma-Aldrich) for imaging. All microscopy images are projections of Z-series made with a Ziess spinning disk confocal microscope. Images being compared in each figure were taken using the same nonsaturating exposure conditions and processed identically (except where indicated otherwise) using Adobe Photoshop for display. 
